< Back to companies
iRegene (睿健医药)

iRegene (睿健医药)

Wuhan, China

We research and develop proprietary chemically-derived allogeneic cell therapy for degenerative diseases like Parkinson’s Disease, Retinal Degenerative Diseases, Ischemic Stroke, etc.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2017
Website
iregene.com/
Only accessible to MedStartr community members. Join now

What do you think of iRegene (睿健医药)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now